Predictors of survival in patients with disease recurrence after radical nephroureterectomy

BJU International

Volumn 113, Issue 6, 2014, Pages 911-917

  Kluth, Luis A ^a,c   Xylinas, Evanguelos ^a,d   Kent, Matthew ^e   Hagiwara, Masayuki ^f   Kikuchi, Eiji ^f   Ikeda, Masaomi ^g   Matsumoto, Kazumasa ^g   Dalpiaz, Orietta ^h   Zigeuner, Richard ^h   Aziz, Atiqullah ⁱ   Fritsche, Hans Martin ⁱ   Deliere, Amanda ^j   Raman, Jay D ^j   Bensalah, Karim ^k   Al Matar, Bikheet ^l   Gakis, Georgios ^l   Novara, Giacomo ^m   Klatte, Tobias ^a   Remzi, Mesut ⁿ   Comploj, Evi ^o   Pycha, Armin ^o   Rouprêt, Morgan ^p   Tagawa, Scott T ^b   Chun, Felix K H ^c   Scherr, Douglas S ^a   Vickers, Andrew J ^e   Shariat, Shahrokh F ^a,b,q   more..

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d Institut Cochin   (France)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^f KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h MEDICAL UNIVERSITY OF GRAZ   (Austria)

ⁱ UNIVERSITY OF REGENSBURG   (Germany)

^j PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^k RENNES UNIVERSITY HOSPITAL   (France)

^l UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^m UNIVERSITY OF PADOVA   (Italy)

ⁿ Landesklinikum Korneuburg ^*  (Austria)

^o CENTRAL HOSPITAL OF BOLZANO   (Italy)

^p PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^q UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

more..

Author keywords

disease recurrence; metastasis; prognosis; survival; upper tract urothelial carcinoma; urothelial cancer

Indexed keywords

ALBUMIN;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CLINICAL EVALUATION; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPOALBUMINEMIA; KARNOFSKY PERFORMANCE STATUS; LEUKOCYTE; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MALE; NEPHROURETERECTOMY; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; SCORING SYSTEM; SURVIVAL RATE; TRANSITIONAL CELL CARCINOMA; VISCERAL METASTASIS;

DISEASE RECURRENCE; METASTASIS; PROGNOSIS; SURVIVAL; UPPER TRACT UROTHELIAL CARCINOMA; UROTHELIAL CANCER;

AGED; CARCINOMA, TRANSITIONAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEPHRECTOMY; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; URETERAL NEOPLASMS;

EID: 84902182613     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12369     Document Type: Article

References (30)

1. Margulis V, Shariat SF, Matin SF, et=al. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer 2009; 115: 1224-1233
2. Xylinas E, Rink M, Cha EK, et=al. Impact of Distal Ureter Management on Oncologic Outcomes Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma. Eur Urol 2014; 65: 210-217
3. Roupret M, Zigeuner R, Palou J, et=al. European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. Eur Urol 2011; 59: 584-594
4. Kikuchi E, Margulis V, Karakiewicz PI, et=al. Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. J Clin Oncol 2009; 27: 612-618
5. Lughezzani G, Burger M, Margulis V, et=al. Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature. Eur Urol 2012; 62: 100-114
6. Zigeuner R, Shariat SF, Margulis V, et=al. Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract. Eur Urol 2010; 57: 575-581
7. Bajorin DF, Dodd PM, Mazumdar M, et=al. Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy. J Clin Oncol 1999; 17: 3173-3181
8. Rink M, Sjoberg D, Comploj E, et=al. Risk of cancer-specific mortality following recurrence after radical nephroureterectomy. Ann Surg Oncol 2012; 19: 4337-4344
9. Edge SB, Compton CC,. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010; 17: 1471-1474
10. Rink M, Ehdaie B, Cha EK, et=al. Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery. Eur Urol 2012; 62: 677-684
11. Chromecki TF, Cha EK, Fajkovic H, et=al. The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy. Eur Urol 2012; 61: 245-253
12. Ehdaie B, Chromecki TF, Lee RK, et=al. Obesity adversely impacts disease specific outcomes in patients with upper tract urothelial carcinoma. J Urol 2011; 186: 66-72
13. Rink M, Xylinas E, Margulis V, et=al. Impact of smoking on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy. Eur Urol 2013; 63: 1082-1090
14. Matsushita K, Mahmoodi BK, Woodward M, et=al. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA 2012; 307: 1941-1951
15. Berod AA, Colin P, Yates DR, et=al. The role of American Society of Anesthesiologists scores in predicting urothelial carcinoma of the upper urinary tract outcome after radical nephroureterectomy: results from a national multi-institutional collaborative study. BJU Int 2012; 110 (11 Pt C): E1035-1040
16. Charlson ME, Pompei P, Ales KL, et=al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987; 40: 373-383
17. Morgan TM, Tang D, Stratton KL, et=al. Preoperative nutritional status is an important predictor of survival in patients undergoing surgery for renal cell carcinoma. Eur Urol 2011; 59: 923-928
18. Ripamonti CI, Farina G, Garassino MC,. Predictive models in palliative care. Cancer 2009; 13 (Suppl.): 3128-3134
19. Nakagawa T, Hara T, Kawahara T, et=al. Prognostic risk stratification of patients with urothelial carcinoma of the urinary bladder who developed recurrence after radical cystectomy. J Urol 2013; 189: 1275-1281
20. Green DA, Rink M, Xylinas E, et=al. Urothelial carcinoma of the bladder and the upper tract: disparate twins. J Urol 2013; 189: 1214-1221
21. Bamias A, Deliveliotis C, Fountzilas G, et=al. Adjuvant chemotherapy with paclitaxel and carboplatin in patients with advanced carcinoma of the upper urinary tract: a study by the Hellenic Cooperative Oncology Group. J Clin Oncol 2004; 22: 2150-2154
22. von der Maase H, Sengelov L, Roberts JT, et=al. Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer. J Clin Oncol 2005; 23: 4602-4608
23. Kawashima A, Nakai Y, Nakayama M, et=al. The result of adjuvant chemotherapy for localized pT3 upper urinary tract carcinoma in a multi-institutional study. World J Urol 2012; 30: 701-706
24. Cordier J, Sonpavde G, Stief CG, et=al. Oncologic outcomes obtained after neoadjuvant and adjuvant chemotherapy for the treatment of urothelial carcinomas of the upper urinary tract: a review. World J Urol 2013; 30: 77-82
25. Hellenthal NJ, Shariat SF, Margulis V, et=al. Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration. J Urol 2009; 182: 900-906
26. Mayr R, May M, Martini T, et=al. Comorbidity and performance indices as predictors of cancer-independent mortality but not of cancer-specific mortality after radical cystectomy for urothelial carcinoma of the bladder. Eur Urol 2012; 62: 662-670
27. Miller DC, Taub DA, Dunn RL, et=al. The impact of co-morbid disease on cancer control and survival following radical cystectomy. J Urol 2003; 169: 105-109
28. Koppie TM, Serio AM, Vickers AJ, et=al. Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer. Cancer 2008; 112: 2384-2392
29. Gibbs J, Cull W, Henderson W, et=al. Preoperative serum albumin level as a predictor of operative mortality and morbidity: results from the National VA Surgical Risk Study. Arch Surg 1999; 134: 36-42
30. Gregg JR, Cookson MS, Phillips S, et=al. Effect of preoperative nutritional deficiency on mortality after radical cystectomy for bladder cancer. J Urol 2011; 185: 90-96